Monsanto Co. announced Tuesday that is has acquired Israel-based plant bio-engineering company, Rosetta Green.
Rosetta Green develops improved plant traits using RNA technology, specializing in the identification of genes that drive key processes in major crops including corn, soybeans and cotton.
The company is based in Rehovot, Israel, at the center of one of the country's major science clusters. The company's operations will remain there, and all employees have accepted jobs with Monsanto.
"All of us at Rosetta Green are excited to being our work with Monsanto," said Limor Zur-Stoller, Rosetta Green's chief financial officer, in a statement. "Israel continues to emerge as a leader in cutting-edge technologies, and this is a great vote of confidence in our research work and scientists."
Most Popular Stories
- Marketo Makes a Mint in IPO: Stock Shoots Up More than 50 Percent
- Bieber Booed at Billboard Awards
- GM Joins Nissan to Supply Small Cargo Vehicle
- Georgia GOP Preaches Minority Outreach
- Ford's Supplier Diversity Program Turns 35
- Ford Trucks See Boost as Roadshow Reaches Saudi Arabia
- Kerry Concerned Over Blasphemy Laws, Anti-Semitism
- GM to Rejoin S&P 500, Akerson Says
- Ladies in White Group Needs Help From Abroad
- Ohio Valley Bank Joins Federal Reserve System
News-To-Go
Advertisement
Advertisement
News Column
Monsanto Buys Israeli Bio-engineering Firm
March 5, 2013
Georgina Gustin
Advertisement
Source: (c)2013 the St. Louis Post-Dispatch. Distributed by MCT Information Services.
Story Tools



